FIPB approves FDI proposals worth Rs 1,186.5 croreIllustrative image – not actual.
The Foreign Investment Promotion Board (FIPB) has approved six investment proposals worth Rs 1,186.5 crore.

The investment proposals cleared by the board include Sanofi Synthelabo India, Idea Cellular Infrastructure Services, and Star Den Media Services.

Netherlands based-Recipharm Participation BV will make an investment of Rs 950 crore. The company is seeking approval for 100 percent FDI in proposed Recipharm Group Indian Investing Company, through which it will completely buy pharmaceutical manufacturing company, Dagny Pharma.

Boehringer Ingelheim India and A Menarini India will invest Rs 156.5 crore and Rs 80 crore respectively.

However, the board rejected three proposals and deferred six proposals including Crest Premedia Solutions, You Broadband India and Scientific Publishing Services.

← All latest storiesBack to top →